Proposal for Pirlimycin

Veterinary Drugs Directorate
Health Products and Food Branch
Health Canada
Holland Cross Complex
Tower A, Ground floor, Suite 14
11 Holland Avenue
Address Locator: 3000A
Ottawa, ON K1A OK9

File No: 9450-5-2

December 20, 2002

The Health Products and Food Branch of Health Canada is considering regulatory amendments which may be of interest to your organization. As the designated contact person of your organization, I would appreciate your collaboration in distributing this information to the attention of all interested parties in your organization to solicit their comments.

The Veterinary Drugs Directorate is proposing to establish Maximum Residue Limits (MRLs) in Table III to Division 15, Part B of the Food and Drug Regulations for pirlimycin in edible tissues of food producing animals and milk as indicated in the following table:

Maximum Residue Limits (MRLs)

Column I Common Name (Or Brand Name of Drug)	Column II Name of Substance For the Drug Analysis Purpose	Column III MRL PPM	Column IV Foods
Pirlimycin	Pirlimycin	0.3	Muscle of cattle
		0.4	Milk
		0.5	Liver of cattle

The results of our Health Risk Assessment shows that residues at this concentration will not pose a health risk for consumers. These proposed MRLs will be prepublished in the Canada Gazette, Part I, after consideration of comments from stakeholders.

I would appreciate receiving your comments on this proposal by February 15, 2003. Comments should be sent to the attention of Dhurata Ikonomi, Partnerships and Outreach Officer, at the above noted address.

Thank you for your cooperation in this matter.

Yours sincerely,

Kathy Dobbin
Director, Strategic Planning
and Stakeholder Relations Division